| [1] |
SHAO Yuling, WANG Na.
Successful treatment of dupilumab-associated nail psoriasis with upadacitinib: a case report and literature review
[J]. China Journal of Leprosy and Skin Diseases, 2026, 42(3): 206-210.
|
| [2] |
BI Zhixia, HAN Jindou.
Dupilumab versus abrocitinib in the treatment of atopic dermatitis: a meta-analysis of efficacy and safety
[J]. China Journal of Leprosy and Skin Diseases, 2026, 42(1): 5-10.
|
| [3] |
BAI Fan, YU Wanlong, XU Yabo, FAN Lifang, LIU Yuyuan, TIAN Zan, LEI Mingjun.
Efficacy of abrocitinib in the treatment of moderate-to-severe prurigo phenotype atopic dermatitis
[J]. China Journal of Leprosy and Skin Diseases, 2025, 41(8): 593-597.
|
| [4] |
SUN Yaru, ZHANG Yisheng, CHEN Yao, CHEN Jinbo, CHEN Liuqing.
Identification of novel therapeutic targets for atopic dermatitis based on genome-wide associationstudies and proteomic colocalization analysis
[J]. China Journal of Leprosy and Skin Diseases, 2025, 41(12): 869-875.
|
| [5] |
LU Yanfang, BAI Hui, SHI Chunrui.
Current situation of atopic dermatitis diagnosis and treatment in Gansu Province
[J]. China Journal of Leprosy and Skin Diseases, 2025, 41(12): 876-881.
|
| [6] |
CHEN Yubao, ZHANG Tao, YIN Dong, REN Shangli.
Efficacy of tripterygium glycosides wilfordii combined with dupilumab in the treatment of atopic dermatitis
[J]. China Journal of Leprosy and Skin Diseases, 2025, 41(11): 797-800.
|
| [7] |
WEI Yanjie, REN Rujiao, ZHANG Lu, ZHANG Peilian.
Dupilumab in the treatment of atopic dermatitis complicated by keloid: a case report
[J]. China Journal of Leprosy and Skin Diseases, 2025, 41(11): 821-823.
|
| [8] |
JIN Lanyan, TANG Xinyun, ZHOU Peimei.
Research advance on the oral microenvironment of atopic dermatitis based on multi-omics technology
[J]. China Journal of Leprosy and Skin Diseases, 2025, 41(11): 836-840.
|
| [9] |
SUN Jingyi, GAO Mingxuan, YAO Xinyu, ZHOU Lingxuan, ZHAO Jiahui.
Advances in understanding the pruritic mechanisms of atopic dermatitis
[J]. China Journal of Leprosy and Skin Diseases, 2025, 41(10): 765-770.
|
| [10] |
YAO Xinyi, HE Tong, YANG Xinya, XU Mingcheng, ZHANG Junling.
Research progress on interleukin-17C in autoimmune skin diseases
[J]. China Journal of Leprosy and Skin Diseases, 2025, 41(1): 69-72.
|
| [11] |
XU Ruoxin, LI Jingyi.
Research progress on the mechanism of neurotransmitter receptors mediating immune disorders in atopic dermatitis
[J]. China Journal of Leprosy and Skin Diseases, 2025, 41(1): 73-78.
|
| [12] |
Dilinuer TAXIMAIMAITI, Palida ABULIZI.
Efficacy and safety of abrocitinib and dupilumab in the treatment of moderate to severe atopic dermatitis
[J]. China Journal of Leprosy and Skin Diseases, 2024, 40(8): 533-537.
|
| [13] |
GUO Shuting, LI Ruijie, YANG Meili, JIN Yaqiao, ZHAO Yiyu, ZHANG Lu, HAN Hui, HAO Yong.
Effect of dupilumab on Staphylococcus aureus colonization in adults with moderate to severe atopic dermatitis
[J]. China Journal of Leprosy and Skin Diseases, 2024, 40(8): 545-549.
|
| [14] |
XU Yuanyuan, GUO Linghong, WU Shuwei, ZHANG Ting, ZHANG Lu, JIANG Xian.
Causal associations between three atopic diseases and alopecia areata: a two-sample Mendelian randomization study
[J]. China Journal of Leprosy and Skin Diseases, 2024, 40(4): 239-244.
|
| [15] |
CHEN Xueqin, SONG Zhiqiang.
Update of skin tissue-resident memory T cells and inflammatory skin diseases recurrence
[J]. China Journal of Leprosy and Skin Diseases, 2024, 40(4): 292-296.
|